-
2023 ends with big game changers for GU cancers
November 4, 2023Chaired by Prof. Axel Merseburger (DE), Prof. Karim Fizazi (FR) and Prof. Valerie Fonteyne (BE), the game-changing session on...
0 -
“If you can’t measure it, you can’t improve it”
November 3, 2023Day two of EMUC23 introduced and implemented the morbidity and mortality (M&M) meeting format during the aptly-titled Plenary Session...
-
What’s new in GU Pathology and WHO classification?
November 10, 2022The Uropathology Symposium (ESUP) delivered the latest updates on the WHO classification of genito-urinary tract tumours for 2022, and...
-
EMUC22 Preview: “Treatment intensification in mHSPC is a hot topic right now”
September 5, 2022The 14th European Multidisciplinary Congress on Urological Cancers (EMUC22) is coming to Budapest, Hungary, from the 10 to 13 November...
-
EMUC22: Relevant topics and Prof. Stenzl’s personal highlights
June 27, 2022Year after year since 2008, the European Multidisciplinary Congress on Urological Cancers (EMUC) provides the urological community with integrative...
-
Personalised approaches to treating GU cancers
November 27, 2021Personalised approaches such as the use of circulating tumour DNA (ctDNA) biomarkers and genetic testing is the way to...
-
Trial updates: NIMBUS, FLAME and IMvigor130
November 27, 2021Presenters of Plenary Session 5 kickstarted day three of EMUC21 and delivered developments on the trials NIMBUS, Focal Lesion...
-
Bladder-preserving strategies unveiled: Topical therapy and TURBT
November 26, 2021In order to preserve the quality of life for non-muscle-invasive bladder cancer (NMIBC) patients as much as possible, bladder-preserving...
-
ESUP Symposium examines the potential of liquid biopsies in uro-oncology
November 14, 2019EMUC19 is a meeting that attracts a wide variety of supplementary meetings, either from EAU Sections like ESUI (Imaging),...
